Table 1 |
||||||
|
ER status is predictive of metastasis in the NKI2 and TRANSBIG data sets. |
||||||
|
Recurrence Event1 |
Recurrence2 (ER+ vs ER-) |
|||||
|
Data set |
ER+ (n) |
ER- (n) |
ER+ (%) |
ER- (%) |
HR |
p-value |
|
|
||||||
|
NKI2 |
225 |
70 |
24 |
47 |
0.4 |
<0.0001 |
|
Wang |
209 |
77 |
32 |
35 |
0.8 |
0.5 |
|
TRANSBIG |
136 |
64 |
13 |
28 |
0.4 |
0.005 |
|
KJX64/KJ125 |
149 |
34 |
22 |
29 |
0.7 |
0.4 |
|
|
||||||
|
1. The percentages indicate the proportion of patients that had metastases within 5 years, stratified by the ER status of their primary tumors. 2. Hazard ratios (HR) and p-values are based on Cox proportional hazards regression analyses and represent the changes in the risk of experiencing a metastatic event for ER positive tumors, as compared to ER negative tumors. |
||||||
|
Mosley and Keri BMC Cancer 2009 9:214 doi:10.1186/1471-2407-9-214 |
||||||
